期刊文献+

OPG/RANKL/RANK系统与骨破坏性疾病 被引量:54

The OPG/RANKL/RANK System and Bone Resorptive Disease
下载PDF
导出
摘要 近年来发现的OPG RANKL RANK系统在破骨细胞生成中起着至关重要的作用 ,是骨骼生理研究领域的重大进展。成骨细胞、骨髓基质细胞、激活的T淋巴细胞表达RANKL ,与破骨细胞前体细胞或成熟破骨细胞表面上的RANK结合后 ,促进破骨细胞的分化及骨吸收活性。成骨细胞及骨髓基质细胞分泌表达OPG可与RANKL竞争性结合 ,从而阻断RANKL与RANK之间的相互作用。体内多种激素或因子通过影响骨髓微环境内的OPG RANKL比率来调节骨代谢。此外 ,乳腺上皮细胞表达有RANK ,孕期在性激素的诱导下可表达RANKL ,OPG RANKL RANK系统在孕期乳腺发育以及母体向胎儿的钙转运过程中发挥重要作用。阻断RANKL RANK通路有望给骨质疏松、类风湿关节炎及癌症骨转移等骨破坏性疾病的治疗开辟新的途径。进一步研究应了解OPG RANKL RANK系统与其它信号传导途径的关系 ,重视骨骼、免疫及内分泌系统之间的相互作用。目前 ,开发与OPG功能相似或促进其表达的合成药物有可能成为具有良好经济效益和社会效益的产业。 The OPG/RANKL/RANK system plays an important role in osteoclastogenesis and represents a great progress in bone biology. RANKL, which expresses on the surface of osteoblast/stromal cells and activated T cells, binds to RANK on the osteoclastic precursors or mature osteoclasts, and promotes osteoclastogenesis and bone resorption. While osteoprotegerin (OPG), which is expressed by osteoblasts/stromal cells, strongly inhibits bone resorption by binding to its ligand RANKL and thereby blocks the interaction between BANKL and RANK. A number of cytokines and hormones exert their effects on bone metabolism by regulating the OPG/RANKL ratio in the bone marrow microenvironment. RANK is also expressed on mammary epithelial cells and RANKL expression in these cells is induced by pregnancy hormones, RANKL and RANK are essential for the formation of the lactating mammary gland and the transmission of maternal calcium to neonates in mammalian species. Modulation of these systems provides a unique opportunity to develop novel therapeutics to inhibit bone loss in osteoporosis, rheumatoid arthritis, and bone metastasis of cancer. Further research should be focused on the cooperation of OPG/RANKL/RANK system with other signal pathways and the interactions among bone remodeling, immune system and endocrinology system. Currently, the development of OPG analogues or compounds which may stimulate OPG expression is becoming an attractive industry which may be profitable to both patients and manufacturers.
出处 《生物工程学报》 CAS CSCD 北大核心 2003年第6期655-660,共6页 Chinese Journal of Biotechnology
关键词 骨保护素 破骨细胞生成 T细胞 骨吸收 骨破坏性疾病 osteoprotegerin, osteoclastogenesis, T lymphocyte, bone resorption
  • 相关文献

参考文献46

  • 1Simonet W S, Lacey D L, Dunstan C R et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89(2):309-319
  • 2Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology,1998,139(3):1329-1337
  • 3Tan K B, H arrop J, Reddy M et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene, 1997, 204:35-46
  • 4Kwon BS, Wang S, Udagawa N et al. TR1, a new member of the tumor necrosis factor receptor family,induces fibroblast proliferation and inhibits osteoclastogenesisand bone resorption. FASEB, 1998, 12: 845-854
  • 5Yun T J, Chaudhary P M, Shu G L et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. Journal of Immunology. 1998, 161: 6113-6121
  • 6Yamaguchi K, Kinosaki M, Goto M et al. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J Biol Chem, 1998, 273(9):5117-5123
  • 7Tomoyasu A, Goto M, Fujise N et al. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factors. Biochem Biophys Res Com, 1998, 245:382-387
  • 8Tsuda E, Goto M, Mochizuki S I et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochemical and Biophysical Research Communications,1997, 234:137-142
  • 9Bucay N, Sarosi I, Dunstan C R et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev,1998,12:1260-1268
  • 10Malyankar U M, Scatena M, Suchland K L et al. Osteoprotegerin is an αv β3-induced, NF-κ B-dependent survival factor for endothelial cells. J Biol Chem, 2000, 275:20959-20962

同被引文献654

引证文献54

二级引证文献351

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部